PATIENT STORIES
Verified cases documenting the full journey — from remote consultation to treatment in China and follow-up care.
Stage IV lung adenocarcinoma · Targeted + immunotherapy · 21 days
In Moscow I was told chemotherapy was my only option. In China, the MDT team ran genomic testing and matched me with a newly approved targeted drug. At three months my tumor had shrunk 40% — at less than half the cost of a Russian private hospital.
Stage II breast cancer · Breast-conserving surgery + IORT · 14 days
From video consultation to surgery took just one week. The chief surgeon preserved my breast and completed intraoperative radiotherapy. I was discharged in four days. A translator stayed at my bedside — I never felt the language barrier.
Prostate cancer · Heavy ion therapy · 28 days
Doctors in Dubai recommended surgical removal, but quality of life mattered to me. Heavy ion therapy required no incision. After 28 sessions my PSA returned to normal — two years on, no sign of recurrence.
Relapsed/refractory DLBCL · CD19 CAR-T · 42 days
After two failed chemotherapy lines, my doctors said no standard options remained. In China I received CD19 CAR-T — 42 days from cell collection to infusion — and my day-28 PET-CT showed complete remission. During the three days of cytokine release syndrome, my coordinator and interpreter stayed outside the ward 24/7, with Russian communication never interrupted. In the West I would have waited over six months at three times the cost.
Relapsed/refractory multiple myeloma · BCMA CAR-T · 35 days
My myeloma kept relapsing after proteasome inhibitors and CD38 antibodies. China’s BCMA CAR-T brought me to MRD-negative deep remission at less than a quarter of the US cost. From expedited medical visas and hotel arrangements during cell manufacturing, to cross-border follow-up three months after infusion, the service team anticipated every step.
Locoregionally advanced NPC · Induction chemo + chemoradiotherapy · 70 days
Hospitals in Vietnam advised immediate radiotherapy, but after the MDT review in China we used the guideline-cited approach: induction chemotherapy followed by concurrent chemoradiotherapy, with IMRT precisely sparing my salivary glands. The tumor completely regressed with far less dry mouth than expected. My records were organized in Vietnamese, Chinese and English, so my doctors back home could continue follow-up seamlessly.
Submit your medical records — our medical advisors will match you with the right hospital and treatment plan within 24 hours.